Oxygen

CHEMBL1234886 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

32.0 g/mol

LogP

-1.1

Phase

4

A colorless gas essential for cell respiration, administered medically to treat or prevent hypoxemia (low blood oxygen) in conditions such as pneumonia, heart failure, COPD, and during anesthesia or intensive care. Supplemental oxygen increases the amount of oxygen available to tissues when normal breathing is insufficient.

分子量

31.9990 g/mol

LogP

-1.10

TPSA

34.10 Å²

リピンスキーの五則

適合

治療領域

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Glaucoma Cardiovascular Disease Age-Related Macular Degeneration Respiratory Disease Pain Management Non-Small Cell Lung Cancer Rheumatoid Arthritis Asthma Chronic Obstructive Pulmonary Disease Alzheimer's Disease Parkinson's Disease Epilepsy Generalized Anxiety Disorder Infectious Disease Melanoma Gastroesophageal Reflux Disease Inflammatory Bowel Disease Obstetrics & Gynecology Systemic Lupus Erythematosus Multiple Sclerosis Chronic Kidney Disease Non-Alcoholic Fatty Liver Disease Stroke Deep Vein Thrombosis / Pulmonary Embolism Obesity Lymphoma Type 2 Diabetes Hypertension Major Depressive Disorder Breast Cancer Atopic Dermatitis Chronic Pain Malaria Heart Failure Atrial Fibrillation Prostate Cancer Colorectal Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

O=O

InChI

InChI=1S/O2/c1-2

Molecular Formula

O2

HBD / HBA

- / 2

回転可能結合数

0

重原子数

2

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A colorless gas essential for cell respiration, administered medically to treat or prevent hypoxemia (low blood oxygen) in conditions such as pneumonia, heart failure, COPD, and during anesthesia or intensive care. Supplemental oxygen increases the amount of oxygen available to tissues when normal breathing is insufficient.

Yes, Oxygen is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1234886. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 977. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Oxygen PillFYIで

構造

クイックデータ

分子式: O2
同義語: 59

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.